Simplex Trading’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Sell
37,800
-1,200
-3% -$3.1K ﹤0.01% 5366
2026
Q1
$109K Sell
39,000
-5,500
-12% -$18.7K ﹤0.01% 4983
2025
Q4
$163K Sell
44,500
-26,900
-38% -$76.7K ﹤0.01% 4444
2025
Q3
$263K Buy
+71,400
New +$181K ﹤0.01% 4624
2024
Q2
Sell
-2,300
Closed -$4K 9058
2024
Q1
$4K Buy
2,300
+300
+15% +$597 ﹤0.01% 8108
2023
Q4
$6K Buy
+2,000
New +$5.29K ﹤0.01% 7742
2022
Q1
Sell
-480
Closed -$18K 10671
2021
Q4
$18K Buy
480
+87
+22% +$3.88K ﹤0.01% 8466
2021
Q3
$21K Sell
393
-7
-2% -$342 ﹤0.01% 8397
2021
Q2
$21K Buy
+400
New +$24.1K ﹤0.01% 8540
2019
Q2
Sell
-1
Closed -$3K 7281
2019
Q1
$3K Hold
1
﹤0.01% 6650
2018
Q4
$1K Hold
1
﹤0.01% 6729
2018
Q3
$3K Sell
1
-2
-67% -$64 ﹤0.01% 6947
2018
Q2
$11K Buy
3
+2
+200% +$113 ﹤0.01% 6287
2018
Q1
$1K Buy
+1
New +$63 ﹤0.01% 5604
2017
Q1
Sell
-4
Closed -$3K 6315
2016
Q4
$3K Sell
4
-14
-78% -$523 ﹤0.01% 4723
2016
Q3
$2K Buy
18
+17
+1,700% +$723 ﹤0.01% 4936
2016
Q2
$1K Buy
+1
New +$47 ﹤0.01% 5271
2016
Q1
Sell
-3
Closed -$1K 5770
2015
Q4
$1K Buy
+3
New +$126 ﹤0.01% 4845

Other funds holding FBIO

Simplex Trading's FBIO Position: Q2 2026 in Review

Simplex Trading reduced its Fortress Biotech (FBIO) stake by 75% in Q2 2026, selling an estimated $113K and leaving 14,508 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6414.

Simplex Trading first reported a position in FBIO in Q4 2015 and has held it in 20 quarters since. The position peaked at $201K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Simplex Trading held 14,508 shares of Fortress Biotech worth $44.4K as of Q2 2026.
  • Simplex Trading sold 43,821 Fortress Biotech shares in Q2 2026, an estimated $113K.
  • Fortress Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6414 holding.
  • Simplex Trading first reported a position in Fortress Biotech in Q4 2015 and has held it in 20 quarters since.
  • Simplex Trading's Fortress Biotech position peaked at $201K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.